Spruce Biosciences, Inc.
SPRB
$52.64
$2.875.77%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -32.31% | 16.25% | -78.35% | -297.29% | 85.28% |
| Total Depreciation and Amortization | 150.40% | 4,940.00% | 66.67% | -57.14% | 16.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -61.46% | -85.27% | 887.69% | 223.94% | -204.66% |
| Change in Net Operating Assets | -381.78% | 1.00% | 4.29% | 136.66% | -834.66% |
| Cash from Operations | -153.32% | -35.25% | -21.44% | 39.78% | 30.64% |
| Capital Expenditure | -1,250.00% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1,250.00% | -- | -- | -- | -- |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -107.65% | 0.25% | -0.25% |
| Issuance of Common Stock | -- | -- | 1,668,800.00% | -- | -- |
| Repurchase of Common Stock | 100.00% | 98.80% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1,960.00% | 94.06% | -- | -- | 200.00% |
| Cash from Financing | 363.28% | -68.86% | 11,217.91% | -0.50% | 2.68% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 715.91% | -86.47% | 768.73% | 38.04% | 29.76% |